Efficacy and Safety of Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma: A Systematic Review of Phase II Trials

Open Access

Ping Fang,

Affiliation Department of Oncology, Institute of Cancer, PLA General Hospital, Beijing, China
⨯
Jin-hua Hu,

Affiliation Department of Digestion, Shandong Province Hospital, Jinan, China
⨯
Zhi-gang Cheng,

Affiliation Department of Ultrasound Intervention, Institute of Cancer, PLA General Hospital, Beijing, China
⨯
Zhe-feng Liu,

Affiliation Department of Oncology, Institute of Cancer, PLA General Hospital, Beijing, China
⨯
Jin-liang Wang,

Affiliation Department of Oncology, Institute of Cancer, PLA General Hospital, Beijing, China
⨯
Shun-chang Jiao

* E-mail: fangping301@sina.com

Affiliation Department of Oncology, Institute of Cancer, PLA General Hospital, Beijing, China
⨯

Reader Comments (0)

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Hemorrhage
Is the Subject Area "Hemorrhage" applicable to this article?

Thanks for your feedback.
Database searching
Is the Subject Area "Database searching" applicable to this article?

Thanks for your feedback.
Phase II clinical investigation
Is the Subject Area "Phase II clinical investigation" applicable to this article?

Thanks for your feedback.
Gastrointestinal cancers
Is the Subject Area "Gastrointestinal cancers" applicable to this article?

Thanks for your feedback.
Systematic reviews
Is the Subject Area "Systematic reviews" applicable to this article?

Thanks for your feedback.